Tibial bone and soft-tissue concentrations following combination therapy with vancomycin and meropenem - evaluated by microdialysis in a porcine model : should patients with open fractures have higher doses of antibiotics?

Antibiotic prophylaxis Cortical bone Meropenem Microdialysis Open fracture Open tibial fractures Vancomycin antibiotics catheters infections porcine model soft-tissues subcutaneous adipose tissue tibial bone vancomycin

Journal

Bone & joint research
ISSN: 2046-3758
Titre abrégé: Bone Joint Res
Pays: England
ID NLM: 101586057

Informations de publication

Date de publication:
Feb 2022
Historique:
entrez: 18 2 2022
pubmed: 19 2 2022
medline: 19 2 2022
Statut: ppublish

Résumé

Prompt and sufficient broad-spectrum empirical antibiotic treatment is key to preventing infection following open tibial fractures. Succeeding co-administration, we dynamically assessed the time for which vancomycin and meropenem concentrations were above relevant epidemiological cut-off (ECOFF) minimal inhibitory concentrations (T > MIC) in tibial compartments for the bacteria most frequently encountered in open fractures. Low and high MIC targets were applied: 1 and 4 µg/ml for vancomycin, and 0.125 and 2 µg/ml for meropenem. Eight pigs received a single dose of 1,000 mg vancomycin and 1,000 mg meropenem simultaneously over 100 minutes and 10 minutes, respectively. Microdialysis catheters were placed for sampling over eight hours in tibial cancellous bone, cortical bone, and adjacent subcutaneous adipose tissue. Venous blood samples were collected as references. Across the targeted ECOFF values, vancomycin displayed longer T > MIC in all the investigated compartments in comparison to meropenem. For both drugs, cortical bone exhibited the shortest T > MIC. For the low MIC targets and across compartments, mean T > MIC ranged between 208 and 449 minutes (46% to 100%) for vancomycin and between 189 and 406 minutes (42% to 90%) for meropenem. For the high MIC targets, mean T > MIC ranged between 30 and 446 minutes (7% to 99%) for vancomycin and between 45 and 181 minutes (10% to 40%) for meropenem. The differences in the T > MIC between the low and high targets illustrate how the interpretation of these results is highly susceptible to the defined MIC target. To encompass any trauma, contamination, or individual tissue differences, a more aggressive dosing approach may be considered to achieve longer T > MIC in all the exposed tissues, and thereby lower the risk of acquiring an infection after open tibial fractures. Cite this article:

Identifiants

pubmed: 35176868
doi: 10.1302/2046-3758.112.BJR-2021-0321.R1
pmc: PMC8882321
doi:

Types de publication

Journal Article

Langues

eng

Pagination

112-120

Références

Injury. 2020 Apr;51(4):1086-1090
pubmed: 32164953
Injury. 2020 May;51 Suppl 2:S57-S63
pubmed: 31679836
JBJS Case Connect. 2018 Jan-Mar;8(1):e8
pubmed: 29443819
J Bone Joint Surg Br. 2008 Mar;90(3):393-9
pubmed: 18310768
J Bone Joint Surg Am. 1976 Jun;58(4):453-8
pubmed: 773941
Eur J Drug Metab Pharmacokinet. 2018 Jun;43(3):259-268
pubmed: 29260505
J Orthop Traumatol. 2020 Jul 18;21(1):10
pubmed: 32683562
Clin Orthop Relat Res. 1989 Jun;(243):36-40
pubmed: 2721073
Surg Infect (Larchmt). 2020 Nov;21(9):766-772
pubmed: 32109188
J Trauma Acute Care Surg. 2012 Apr;72(4):1062-7
pubmed: 22491628
Plast Reconstr Surg. 1990 Dec;86(6):1152-62; discussion 1163
pubmed: 2243859
Int J Antimicrob Agents. 2015 Oct;46(4):434-8
pubmed: 26260192
Wound Repair Regen. 2018 Mar;26(2):127-135
pubmed: 29802752
J Orthop Trauma. 2017 Mar;31(3):121-126
pubmed: 27984446
J Neurosci Methods. 1991 Nov;40(1):31-8
pubmed: 1795551
Pharm Res. 2015 Jul;32(7):2410-8
pubmed: 25630818
Bone Joint Res. 2018 Aug 4;7(7):447-456
pubmed: 30123494
Antimicrob Agents Chemother. 2018 Apr 26;62(5):
pubmed: 29530848
J Bone Miner Res. 2017 May;32(5):985-990
pubmed: 27933662
Lancet. 2004 Jul 24-30;364(9431):369-79
pubmed: 15276398
Bone Joint Res. 2021 Jan;10(1):60-67
pubmed: 33448872
J Orthop Trauma. 2014 Nov;28(11):613-9
pubmed: 25050748
J Orthop Trauma. 2020 Jan;34(1):30-41
pubmed: 31567902
Antimicrob Agents Chemother. 1998 Mar;42(3):521-7
pubmed: 9517926
J Bone Joint Surg Am. 2007 Apr;89(4):884-95
pubmed: 17432452
Acta Orthop. 2018 Dec;89(6):683-688
pubmed: 30080983
Clin Pharmacokinet. 2005;44(9):895-913
pubmed: 16122279
Vet Pathol. 2012 Mar;49(2):344-56
pubmed: 21441112
J Antimicrob Chemother. 2009 Jul;64(1):142-50
pubmed: 19398460
Spine J. 2016 Mar;16(3):432-8
pubmed: 26620946
Anat Rec A Discov Mol Cell Evol Biol. 2004 Jun;278(2):505-13
pubmed: 15164337
Bone Joint Res. 2019 Aug 2;8(7):313-322
pubmed: 31463039
Int Orthop. 2015 Jun;39(6):1159-66
pubmed: 25750130
Injury. 2014 Jul;45(7):1025-7
pubmed: 24794617
Clin Orthop Relat Res. 1997 Jun;(339):71-5
pubmed: 9186203
Bone Joint Res. 2021 Jun;10(6):351-353
pubmed: 34076501
Injury. 2011 Dec;42(12):1408-15
pubmed: 22019355

Auteurs

Sofus Ørbæk Vittrup (SØ)

Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Pelle Hanberg (P)

Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Martin Bruun Knudsen (MB)

Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark.

Sara Kousgaard Tøstesen (SK)

Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Josephine Olsen Kipp (JO)

Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.

Jakob Hansen (J)

Department of Forensic Medicine, Aarhus University Hospital, Aarhus, Denmark.

Nis Pedersen Jørgensen (NP)

Department of Infectious Diseases, Aarhus University Hospital, Aarhus, Denmark.

Maiken Stilling (M)

Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark.

Mats Bue (M)

Aarhus Denmark Microdialysis Research (ADMIRE), Orthopaedic Research Laboratory, Aarhus University Hospital, Aarhus, Denmark.
Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
Department of Orthopaedic Surgery, Aarhus University Hospital, Aarhus, Denmark.

Classifications MeSH